Listed by the USPTO as LOCKARD, JON MCCLELLAND
Tech Center 1600 • Art Units: 1647
This examiner grants 74% of resolved cases
LOCKARD, JON MCCLELLAND handles applications in Tech Center 1600 and Art Unit 1647. The record includes 857 resolved cases, a 74.4% allowance rate, and a median of 898 days to allowance. Interview lift is 27.4%, indicating that interviews were associated with a meaningful improvement in allowance outcomes.
The listed companies are Vellera Therapeutics Inc., Kodiak Sciences Inc., and Janssen Pharmaceuticals Inc. Knobbe, Martens, Olson & Bear, LLP, McDermott Will & Schulte LLP, and BakerHostetler are the associated firms. The combination of substantial experience, a favorable allowance rate, and positive interview lift supports early preparation for examiner interaction in biotechnology matters.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18037482 | IMMUNO-ONCOLOGY TARGETS TO IMPROVE T-CELL METABOLIC RESPONSE | Non-Final OA | The Johns Hopkins University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.4% of resolved applications examined by Jon Mcclelland Lockard were allowed (857 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.
This examiner's interview lift is +27.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jon Mcclelland Lockard took 898 days on average from filing to allowance.
Jon Mcclelland Lockard examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
